253 related articles for article (PubMed ID: 11040052)
1. Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry.
Newman-Tancredi A; Audinot V; Moreira C; Verrièle L; Millan MJ
Mol Pharmacol; 2000 Nov; 58(5):1042-9. PubMed ID: 11040052
[TBL] [Abstract][Full Text] [Related]
2. h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HT.
Newman-Tancredi A; Cussac D; Marini L; Touzard M; Millan MJ
Br J Pharmacol; 2003 Mar; 138(6):1077-84. PubMed ID: 12684263
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activity at serotonin 5-HT(1D) receptors: detection by homologous GTPgammaS versus [(35)S]-GTPgammaS binding isotherms.
Audinot V; Newman-Tancredi A; Millan MJ
Neuropharmacology; 2001; 40(1):57-64. PubMed ID: 11077071
[TBL] [Abstract][Full Text] [Related]
4. Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Millan MJ
Neuropharmacology; 1997; 36(4-5):451-9. PubMed ID: 9225269
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
Newman-Tancredi A; Verrièle L; Millan MJ
Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
[TBL] [Abstract][Full Text] [Related]
6. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
Cosi C; Koek W
Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
[TBL] [Abstract][Full Text] [Related]
7. 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.
Odagaki Y; Toyoshima R
Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):335-45. PubMed ID: 16491386
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking.
Cussac D; Newman-Tancredi A; Duqueyroix D; Pasteau V; Millan MJ
Mol Pharmacol; 2002 Sep; 62(3):578-89. PubMed ID: 12181434
[TBL] [Abstract][Full Text] [Related]
9. Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Newman-Tancredi A; Gavaudan S; Conte C; Chaput C; Touzard M; Verrièle L; Audinot V; Millan MJ
Eur J Pharmacol; 1998 Aug; 355(2-3):245-56. PubMed ID: 9760039
[TBL] [Abstract][Full Text] [Related]
10. Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
Newman-Tancredi A; Cussac D; Marini L; Millan MJ
Mol Pharmacol; 2002 Sep; 62(3):590-601. PubMed ID: 12181435
[TBL] [Abstract][Full Text] [Related]
11. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor.
Bhalla P; Sharma HS; Ma X; Wurch T; Pauwels PJ; Saxena PR
Br J Pharmacol; 2001 Jul; 133(6):891-901. PubMed ID: 11454663
[TBL] [Abstract][Full Text] [Related]
13. Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivo.
Millan MJ; Gobert A; Audinot V; Dekeyne A; Newman-Tancredi A
Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):61S-67S. PubMed ID: 10432490
[TBL] [Abstract][Full Text] [Related]
14. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
Pauwels PJ; Gouble A; Wurch T
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.
Newman-Tancredi A; Rivet JM; Cussac D; Touzard M; Chaput C; Marini L; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):188-99. PubMed ID: 12923612
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterisation of a cloned dog 5-HT1B receptor cell line.
Beer MS; Heald MA; McAllister G; Stanton JA
Eur J Pharmacol; 1998 Oct; 360(1):117-21. PubMed ID: 9845281
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterisation of [35S]-GTPgammaS binding to Chinese hamster ovary cell membranes stably expressing cloned human 5-HT1D receptor subtypes.
Thomas DR; Faruq SA; Balcarek JM; Brown AM
J Recept Signal Transduct Res; 1995; 15(1-4):199-211. PubMed ID: 8903941
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.
Newman-Tancredi A; Verrièle L; Touzard M; Millan MJ
Eur J Pharmacol; 2001 Oct; 428(2):177-84. PubMed ID: 11675034
[TBL] [Abstract][Full Text] [Related]
19. Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors.
Audinot V; Newman-Tancredi A; Cussac D; Millan MJ
Neuropsychopharmacology; 2001 Sep; 25(3):410-22. PubMed ID: 11522469
[TBL] [Abstract][Full Text] [Related]
20. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
